Skip to content
Clinical Trials – home
Universita' Degli Studi Di Roma Tor Vergata
Sponsor

Universita' Degli Studi Di Roma Tor Vergata

Italy Via Montpellier 1, 00133 Rome, Italy

About the sponsor

Clinical research in ulcerative colitis with a focus on treatment response in ulcerative rectal colitis and factors associated with response to tofacitinib therapy.

  • Ulcerative colitis
  • Ulcerative rectal colitis
  • Tofacitinib
  • Treatment response prediction

Interest extends to clinical features that may help identify patients most likely to benefit from targeted management in inflammatory bowel disease.

About Specializations

Universita' Degli Studi Di Roma Tor Vergata runs clinical trials in conditions such as Insomnia, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Daridorexant
  • Sponsor:Universita' Degli Studi Di Roma Tor Vergata
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Tofacitinib
  • Sponsor:Universita' Degli Studi Di Roma Tor Vergata

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.